The FDA, in collaboration with the Reagan-Udall Foundation, is set to host its sixth Online Controlled Substances Summit on September 11, 2025. This event underscores the agency’s ongoing commitment to addressing the complexities surrounding controlled substances in the pharmaceutical landscape.
As regulatory pressures and public health concerns continue to evolve, this summit will provide a vital platform for stakeholders across the pharmaceutical sector, including regulatory professionals, quality assurance teams, and supply chain managers. Participants will engage in discussions that highlight current challenges and innovative solutions in the management of controlled substances.
The implications of this summit are significant, as it aims to foster collaboration and knowledge sharing among industry experts. By focusing on regulatory compliance and best practices, the event will help shape the future of controlled substances management, ultimately enhancing patient safety and product integrity.
